investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Cytokines and T Cell Development

Scott Durum

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Scott Durum

National Cancer Institute (NIH)

Rockville, United States

Related projects

H Leighton Grimes

Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias

Leukaemia

Hematology and hematologic malignancies

Ravindra Majeti

Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML

Leukaemia

Hematology and hematologic malignancies

Catherine Ju-Ying Wu

(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL

Leukaemia

Hematology and hematologic malignancies

Charles G Mullighan

Functional analysis of leukemic CREBBP mutations

Leukaemia

Pediatric oncology or childhood cancer

Bruce R Blazar

Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)

Leukaemia

Hematology and hematologic malignancies

Elizabeth J Shpall

IMPROVING CORD BLOOD TRANSPLANTATION

Leukaemia

Pediatric oncology or childhood cancer

Micah A Luftig

Host Pathways Regulating Epstein-Barr Virus-Mediated B Cell Growth Transformation

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Luca Gattinoni

Programming T Cell Fates for Therapeutic Use

Leukaemia

Hematology and hematologic malignancies

Christophe P Nicot

HTLV-I Tax induces DNA Breaks and Inhibits HR Repair through Activation of NF-kB

Leukaemia

Hematology and hematologic malignancies